BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33757592)

  • 1. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis.
    Nagasaki K; Nakashima A; Tamura R; Ishiuchi N; Honda K; Ueno T; Doi S; Kato Y; Masaki T
    Stem Cell Res Ther; 2021 Mar; 12(1):203. PubMed ID: 33757592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
    Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
    Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis.
    Ishiuchi N; Nakashima A; Doi S; Kanai R; Maeda S; Takahashi S; Nagao M; Masaki T
    Stem Cell Res Ther; 2021 Aug; 12(1):472. PubMed ID: 34425892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis.
    Yoshida K; Nakashima A; Doi S; Ueno T; Okubo T; Kawano KI; Kanawa M; Kato Y; Higashi Y; Masaki T
    Stem Cells Transl Med; 2018 Dec; 7(12):893-905. PubMed ID: 30269426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.
    Takao S; Nakashima T; Masuda T; Namba M; Sakamoto S; Yamaguchi K; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takahashi S; Nakashima A; Hattori N
    Stem Cell Res Ther; 2021 Sep; 12(1):506. PubMed ID: 34530920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6.
    Wang N; Li Q; Zhang L; Lin H; Hu J; Li D; Shi S; Cui S; Zhou J; Ji J; Wan J; Cai G; Chen X
    PLoS One; 2012; 7(8):e43768. PubMed ID: 22912904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects.
    Kadono M; Nakashima A; Ishiuchi N; Sasaki K; Miura Y; Maeda S; Fujita A; Sasaki A; Nagamatsu S; Masaki T
    Stem Cell Res Ther; 2023 Nov; 14(1):337. PubMed ID: 37993965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived mesenchymal stem cells attenuate dialysis-induced peritoneal fibrosis by modulating macrophage polarization via interleukin-6.
    Yang CY; Chang PY; Chen JY; Wu BS; Yang AH; Lee OK
    Stem Cell Res Ther; 2021 Mar; 12(1):193. PubMed ID: 33741073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis.
    Giri H; Biswas I; Rezaie AR
    J Thromb Haemost; 2023 Jan; 21(1):133-144. PubMed ID: 36695376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.
    Lee YC; Hung SY; Liou HH; Lin TM; Tsai CH; Lin SH; Tsai YS; Chang MY; Wang HH; Ho LC; Chen YT; Wu CF; Chen HC; Chen HP; Liu KW; Chen CI; She KM; Wang HK; Lin CW; Chiou YY
    Biomed Res Int; 2015; 2015():595030. PubMed ID: 26495304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
    Ishiuchi N; Nakashima A; Doi S; Yoshida K; Maeda S; Kanai R; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
    Stem Cell Res Ther; 2020 Mar; 11(1):130. PubMed ID: 32197638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord mesenchymal stem cells facilitate the up-regulation of miR-153-3p, whereby attenuating MGO-induced peritoneal fibrosis in rats.
    Li D; Lu Z; Li X; Xu Z; Jiang J; Zheng Z; Jia J; Lin S; Yan T
    J Cell Mol Med; 2018 Jul; 22(7):3452-3463. PubMed ID: 29654659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
    Ju KD; Kim HJ; Tsogbadrakh B; Lee J; Ryu H; Cho EJ; Hwang YH; Kim K; Yang J; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F342-50. PubMed ID: 26661649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
    Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed administration of suramin attenuates peritoneal fibrosis in rats.
    Xiong C; Liu N; Shao X; Sharif S; Zou H; Zhuang S
    BMC Nephrol; 2019 Nov; 20(1):411. PubMed ID: 31727005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial-mesenchymal transition.
    Wakabayashi K; Hamada C; Kanda R; Nakano T; Io H; Horikoshi S; Tomino Y
    J Nephrol; 2014 Oct; 27(5):507-14. PubMed ID: 25146164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.